BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17044837)

  • 1. Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Mercadal S; Martinez A; Nomdedeu B; Rozman M; Gaya A; Salamero O; Campo E
    Eur J Haematol; 2006 Nov; 77(5):442-4. PubMed ID: 17044837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
    Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
    Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes lymphadenitis in association with chronic lymphocytic leukemia.
    Higgins JP; Warnke RA
    Cancer; 1999 Oct; 86(7):1210-5. PubMed ID: 10506706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
    Thornton PD; Bellas C; Santon A; Shah G; Pocock C; Wotherspoon AC; Matutes E; Catovsky D
    Leuk Res; 2005 Apr; 29(4):389-95. PubMed ID: 15725472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
    Rath J; Geisler C; Christiansen CB; Hastrup N; Madsen HO; Andersen MK; Pedersen LB; Jurlander J
    Haematologica; 2008 Sep; 93(9):1424-6. PubMed ID: 18641020
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine.
    Laurenti L; Garzia M; Sabatelli M; Piccioni P; Sora' F; Leone G
    Haematologica; 2002 Nov; 87(11):ECR33. PubMed ID: 12414359
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
    Chaker L; Segeren CM; Bot FJ; Maartense E
    Eur J Haematol; 2010 Jul; 85(1):91-2. PubMed ID: 20331737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Lu Y; Sun LR; Pang XY; Lu ZH; Sui AH
    Ai Zheng; 2007 Jan; 26(1):54-7. PubMed ID: 17222368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of herpes simplex virus type 1 in addition to Epstein-Bar virus in tonsils using a new multiplex polymerase chain reaction assay.
    Sahin F; Gerceker D; Karasartova D; Ozsan TM
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):47-51. PubMed ID: 17141448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine for chronic lymphocytic leukemia.
    Copur MS; Ledakis P; Muhvic J
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
    Orlandi EM; Baldanti F; Citro A; Pochintesta L; Gatti M; Lazzarino M
    Haematologica; 2008 Nov; 93(11):1758-60. PubMed ID: 18790800
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
    Engelmann I; Petzold DR; Kosinska A; Hepkema BG; Schulz TF; Heim A
    J Med Virol; 2008 Mar; 80(3):467-77. PubMed ID: 18205230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute retinal necrosis features, management, and outcomes.
    Lau CH; Missotten T; Salzmann J; Lightman SL
    Ophthalmology; 2007 Apr; 114(4):756-62. PubMed ID: 17184841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Bacchu S; Fegan C; Neal J
    Br J Haematol; 2007 Nov; 139(3):349. PubMed ID: 17784883
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C; Coiffier B
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
    J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.